Publication:
Microbiota translocation following intestinal barrier disruption promotes Mincle-mediated training of myeloid progenitors in the bone marrow.

dc.contributor.authorRobles-Vera, Iñaki
dc.contributor.authorJarit-Cabanillas, Aitor
dc.contributor.authorBrandi, Paola
dc.contributor.authorMartínez-López, María
dc.contributor.authorMartínez-Cano, Sarai
dc.contributor.authorRodrigo-Tapias, Manuel
dc.contributor.authorFemenía-Muiña, Marcos
dc.contributor.authorRedondo-Urzainqui, Ana
dc.contributor.authorNuñez, Vanesa
dc.contributor.authorGonzález-Correa, Cristina
dc.contributor.authorMoleón, Javier
dc.contributor.authorDuarte, Juan
dc.contributor.authorConejero, Laura
dc.contributor.authorMata-Martínez, Pablo
dc.contributor.authorDíez-Rivero, Carmen María
dc.contributor.authorBergón-Gutiérrez, Marta
dc.contributor.authorFernández-López, Iván
dc.contributor.authorGómez, Manuel J
dc.contributor.authorQuintas, Ana
dc.contributor.authorDopazo, Ana
dc.contributor.authorSánchez-Cabo, Fátima
dc.contributor.authorPariente, Esther
dc.contributor.authorDel Fresno, Carlos
dc.contributor.authorSubiza, José Luis
dc.contributor.authorIborra, Salvador
dc.contributor.authorSancho, David
dc.contributor.funderFundación La Caixa
dc.contributor.funderComunidad de Madrid (España)
dc.contributor.funderMinisterio de Economía y Competitividad (España)
dc.contributor.funderInstituto de Salud Carlos III
dc.contributor.funderMinisterio de Ciencia, Innovación y Universidades (España)
dc.contributor.funderAgencia Estatal de Investigación (España)
dc.contributor.funderUnión Europea. Comisión Europea. NextGenerationEU
dc.contributor.funderAsociación Española Contra el Cáncer
dc.contributor.funderUnión Europea. Comisión Europea. European Research Council (ERC)
dc.contributor.funderMinisterio de Ciencia e Innovación. Centro de Excelencia Severo Ochoa (España)
dc.contributor.funderFundación ProCNIC
dc.date.accessioned2025-07-09T13:06:28Z
dc.date.available2025-07-09T13:06:28Z
dc.date.issued2025-02-11
dc.description.abstractImpairment of the intestinal barrier allows the systemic translocation of commensal bacteria, inducing a proinflammatory state in the host. Here, we investigated innate immune responses following increased gut permeability upon administration of dextran sulfate sodium (DSS) in mice. We found that Enterococcus faecalis translocated to the bone marrow following DSS treatment and induced trained immunity (TI) hallmarks in bone-marrow-derived mouse macrophages and human monocytes. DSS treatment or heat-killed E. faecalis reprogrammed bone marrow progenitors (BMPs), resulting in enhanced inflammatory responses in vitro and in vivo and protection against subsequent pathogen infections. The C-type lectin receptor Mincle (Clec4e) was essential for E. faecalis-induced TI in BMPs. Clec4e mice showed impaired TI upon E. faecalis administration and reduced pathology following DSS treatment. Thus, Mincle sensing of E. faecalis induces TI that may have long-term effects on pathologies associated with increased gut permeability.
dc.description.peerreviewed
dc.description.tableofcontentsWe are grateful to members of the D.S. laboratory for discussions and critical reading of the manuscript, particularly to Gillian Dunphy. We thank Je´roˆ me Nigou for providing Mincle ligands and the CNIC facilities and personnel for assistance. I.R.-V. is funded by FJC2021-048099-I. M.M.-L. is supported by a Junior Leader postdoctoral fellowship from ‘‘la Caixa’’ Foundation (116923). A.R.-U. is supported by Community of Madrid (PIPF-2022/SALGL-2458). J.M. and C.G.-C. are predoctoral fellows of MINECO and Junta de Andalucı´a, respectively. C.d.F. is funded by Instituto de Salud Carlos III through the projects CP20/00106 and PI21-01178 (co-funded by European Union). J.D.’s laboratory is funded by Spanish Ministerio de Ciencia, Innovacio´ n y Universidades (MICIU) PID2020-116347RB-I00/AEI/10.13039/501100011033. Work in the D.S. laboratory is funded by the CNIC; by MICIU grants PID2022-137712OB-I00, CPP2021-008310, and CPP2022-009762 from the MICIU/AEI/10.13039/501100011033 Agencia Estatal de Investigacio´ n (AEI) and Unio´ n Europea NextGenerationEU/PRTR; by the Comunidad de Madrid (P2022/BMD-7333 INMUNOVAR-CM); by the Scientific Foundation of the Spanish Association Against Cancer (AECC-PRYGN246642SANC); by Worldwide Cancer Research (WWCR-25-0080); by the European Union (ERC-2023-PoC); by a research agreement with Inmunotek S.L.; and by ‘‘la Caixa’’ Foundation (LCF/PR/HR23/52430012 and LCF/PR/HR22/52420019). The CNIC is supported by the Instituto de Salud Carlos III (ISCIII), the MICIU, and the Pro CNIC Foundation, and it is a Severo Ochoa Center of Excellence (CEX2020-001041-S, funded by MICIU/AEI/10.13039/501100011033). Work in the S.I. laboratory is funded by the MICIU, AEI, and FEDER through grants RTI2018-094484-B-I00, PID2021-125415OB-I00, and RYC-2016-19463.
dc.identifier.citationImmunity. 2025 Feb 11;58(2):381-396.e9.
dc.identifier.journalImmunity
dc.identifier.pubmedID39848243
dc.identifier.urihttps://hdl.handle.net/20.500.12105/26810
dc.language.isoeng
dc.publisherCell Press
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/FJC2021-048099-I
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/PIPF-2022/SALGL-2458
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/CP20/00106
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/PI21-01178
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/PID2020-116347RB-I00
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/AEI/10.13039/501100011033
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/PID2022-137712OB-I00
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/CPP2021-008310
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/CPP2022-009762
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/MICIU/AEI/10.13039/501100011033
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/P2022/BMD-7333
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/AECC-PRYGN246642SANC
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/LCF/PR/HR23/52430012
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/LCF/PR/HR22/52420019
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/CEX2020-001041-S
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/MICIU/AEI/10.13039/501100011033
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/RTI2018-094484-B-I00
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/PID2021-125415OB-I00
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/RYC-2016-19463
dc.relation.publisherversionhttps://doi.org/10.1016/j.immuni.2024.12.012
dc.repisalud.institucionCNIC
dc.repisalud.orgCNICCNIC::Grupos de investigación::Inmunobiología
dc.rights.accessRightsopen access
dc.rights.licenseAttribution-NonCommercial-NoDerivatives 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subjectMincle receptor
dc.subjectbone marrow progenitors
dc.subjectgut bacterial translocation
dc.subjectinflammation
dc.subjectmacrophages
dc.subjecttrained immunity
dc.titleMicrobiota translocation following intestinal barrier disruption promotes Mincle-mediated training of myeloid progenitors in the bone marrow.
dc.typeresearch article
dc.type.hasVersionVoR
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Microbiota translocation following intestinal_Immunity_2025.pdf
Size:
4.61 MB
Format:
Adobe Portable Document Format